Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C

Journal of Gastroenterology

Volumn 39, Issue 12, 2004, Pages 1202-1204

  Sho, Yukihiko ^a   Fujisaki, Kunio ^b   Sakashita, Hironori ^c   Yamaguchi, Koichi ^d   Tahara, Kenji ^e   Kubozono, Osamu ^e   Ido, Akio ^f,g   Tsubouchi, Hirohito ^g  

^a IMAMURA BUN IN HOSPITAL   (Japan)

^b Department of Internal Medicine   (Japan)

^c Jiaikai Imamura Hospital   (Japan)

^d Yamaguchi Urban Clinic   (Japan)

^e Kagaoshima Kouseiren Hospital   (Japan)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

^g UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Chronic hepatitis C; Interferon; Juzen taiho to; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN; INTERFERON; KAMPO; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; SHI QUAN DA BU TANG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANEMIA, HEMOLYTIC; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MEDICINE, KAMPO; MIDDLE AGED; RETROSPECTIVE STUDIES; RIBAVIRIN;

EID: 11344263838     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1472-0     Document Type: Article

References (7)

1. Tsubota A, Arase Y, Suzuki F, Suzuki Y, Akuta N, Hosaka T, et al. High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients with hepatitis C virus genotype 1b with a high baseline viral load. J Gastroenterol 2004;39:155-61.
2. EASL. International Consensus Conference on Hepatitis C: Paris, 26-28 February 1999, Consensus Statement. J Hepatol 1999;30:956-61.
3. De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage. Hepatology 2000;31:997-1004.
4. Hisha H, Yamada H, Sakurai M, Kiyohara H, Li Y, Yu C, et al. Isolation and identification of hematopoietic stem cell-stimulating substances from kampo (Japanese herbal) medicine, Juzen-taihoto. Blood 1997;90:1022-30.
5. Dai Y, Kato M, Takeda K, Kawamoto Y, Akhand AA, Hossain K, et al. T-cell-immunity-based inhibitory effect of orally administered herbal medicine Juzen-taiho-to on the growth of primarily developed melanocytic tumor in RET-transgenic mice. J Invest Dermatol 2001;117:694-701.
6. Saiki I. A Kampo medicine "Juzen-taiho-to" - prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biol Pharm Bull 2000;23:677-88.
7. Amaraa R, Nareckova H, Urbanek P, Fucikova T. Immunological predictors of different responses to combination therapy with interferon a and ribavirin in patients with chronic hepatitis C. J Gastroenterol 2003;38:254-9.